Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

Research & Selected Publications

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response
Authors:

Valentine MC, Mullen MM, Kotnik EN, one or more additional authors omitted Fuh KC

Journal & Year:

Cancer Res | 2025

Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
Authors:

Lomonosova E, Loeb M, Rodriguez K, one or more additional authors omitted Mullen MM

Journal & Year:

bioRxiv | 2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted Mullen MM

Journal & Year:

J Clin Invest | 2025

Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted Mullen M

Journal & Year:

bioRxiv | 2024

Tumour evolution and microenvironment interactions in 2D and 3D space
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Mullen MM, one or more additional authors omitted Ding L

Journal & Year:

Nature | 2024

A toolkit for a modern gynecologic oncology tissue bank
Authors:

Graham O, Rodriguez J, Abbott R, one or more additional authors omitted Mullen MM

Journal & Year:

Gynecol Oncol | 2024

Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial
Authors:

Mullen MM, Grither WR, Millimet H, one or more additional authors omitted Kuroki LM

Journal & Year:

Gynecol Oncol Rep | 2024